Navigation Links
Akaza Research Releases New Version of OpenClinica Electronic Data Capture (EDC) Software; Targets Industry Clinical Trials
Date:9/19/2008

OpenClinica 2.5 represents a significant milestone for the growing open source clincial trials software. This release contains a host of improvements particularly oriented towards the needs of regulated industry sponsored clinical trials.

Cambridge, MA (PRWEB) September 19, 2008 -- Akaza Research announces the availability of OpenClinica 2.5, the popular open source http://www.openclinica.org/section.php?sid=1 [clinical trials software]. This release marks a major milestone for users of OpenClinica by adding a host of features, many of which are designed to better support regulated industry sponsored clinical trials.

OpenClinica 2.5 is freely available for download at http://www.openclinica.org.

Among the numerous improvements that comprise this release are:

-   New study monitoring and query management tools and reports
-   Import of data from external sources
-   Enhanced eCRF features, including scoring, multivariate edit checks, and rules
-   User roles for monitors and data managers
-   Electronic signature capabilities
-   Improved auditing and logging capabilities
-   Simpler CRF upload

In addition, this release provides a number of architectural enhancements:

-   Faster performance and improved scalability
-   Out-of-the box support for the Oracle database
-   Translation into 3 new languages: French, Italian, and Portuguese

"Many thanks to our partners in the OpenClinica community who have contributed to this substantial release," said Paul Galvin, who manages OpenClinica development for Akaza Research.
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. eResearchTechnology, Inc. to Present at the UBS Global Life Sciences Conference on September 23rd, 2008
2. Peptimmune Presentation at Upcoming World Congress on Treatment and Research in Multiple Sclerosis
3. Amicus Therapeutics Opens Research Facility in San Diego
4. Exosome Diagnostics Appoints Johan Skog, Ph.D., as Director of Genetics Research
5. $1.6 Million Agreement to Accelerate Fragile X Research, Inspire Hope
6. Pressure BioSciences, Inc. Announces Research Agreement With the US Army Medical Research Institute of Infectious Diseases (USAMRIID)
7. Top Biopharma Company Adopts BioFortis Translational Research Software for Centralized Management and Mining of Clinical Biomarker Data
8. Johnson & Johnson Honors 2008 Recipients of The Dr. Paul Janssen Award for Biomedical Research
9. Intarcia Therapeutics, Inc. Announces Appointment of Kenneth Luskey, M.D. as Vice President, Clinical Research
10. OncologySTAT Advisors Name Years Top Developments in Cancer Treatment and Research
11. Dartmouth researchers advance cellulosic ethanol production
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Akaza Research Releases New Version of OpenClinica Electronic Data Capture (EDC) Software; Targets Industry Clinical Trials 
(Date:12/19/2014)... YORK , Dec. 18, 2014 Relmada ... therapies for the treatment of chronic pain, announced the ... today. "This was a transformational year in ... promising future for our company," said Sergio Traversa ... year, we have executed on key financial, human resource ...
(Date:12/17/2014)... BASKING RIDGE, N.J. (PRWEB) December 17, 2014 ... Ipsen (Euronext: IPN; ADR: IPSEY), ... 120 mg (referred to as Somatuline®) was approved ... for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) ... differentiated, locally advanced or metastatic disease to improve ...
(Date:12/17/2014)... December 17, 2014 Audacity, a leading ... and member of the Huntsworth Health Group, is proud ... executive team. In her role, Gonzales will serve as ... are incredibly honored to welcome a talent of Jamie’s ... CEO, Gaëtan Fraikin. “She is a proven healthcare innovation ...
(Date:12/17/2014)... LEXINGTON, Mass. , Dec. 17, 2014   ... a biopharmaceutical company developing therapeutic products for rare disorders, ... Healthcare Conference being held in San Francisco, ... , President and Chief Executive Officer, will present on ... p.m. EST).  The presentation will be webcast live and ...
Breaking Biology Technology:Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2
... United States Catholic Bishops did not waver, and after ... . , , Wisconsin Right to Life , however, is ... stem cells from human embryos that does not destroy embryos, and ... , ,While various objections still remain, could the fact that this ...
... ilwaukee, Wis. - Teresa Esser sees incredible ... as the new director of the Milwaukee-based Silicon ... more of that opportunity realized. , ,While others are ... in Wisconsin, particularly in the tech sector, Esser sees ...
... - Ten years from now, when people sit in ... clarity, they probably won't think much about the people that ... hard at work as movie-goers take in the last reels ... situated in Hollywood. One of them is Jane Durment, CIO ...
Cached Biology Technology:There's a new dynamic in the stem cell debate 2There's a new dynamic in the stem cell debate 3There's a new dynamic in the stem cell debate 4New Silicon Pastures director envisions more home cooking for Wisconsin angels 2New Silicon Pastures director envisions more home cooking for Wisconsin angels 3New Silicon Pastures director envisions more home cooking for Wisconsin angels 4New Silicon Pastures director envisions more home cooking for Wisconsin angels 5New Silicon Pastures director envisions more home cooking for Wisconsin angels 6CIO Leadership Series: Jane Durment, Marcus Corp. 2CIO Leadership Series: Jane Durment, Marcus Corp. 3CIO Leadership Series: Jane Durment, Marcus Corp. 4
(Date:12/11/2014)... N.C. , Dec. 10, 2014  That blood pressure ... quite a while. Hypertension – the medical term for high ... the early 1800s, and the inflatable cuff that,s used in ... doesn,t, however, mean there,s nothing new about hypertension, its triggers ... long-held beliefs about the condition and the best ways to ...
(Date:12/10/2014)... YORK , Dec. 8, 2014 You,ve been ... banking account but can,t remember your password, site key or ... Who was your first grade teacher? Today, ... the app that will finally put an end ... – 1U TM . 1U leverages a user,s ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Wake Forest Baptist ... education building for its School of Medicine. Funding for ... larger capital campaign that will be publicly launched next ... be located in the former 60 series R.J. Reynolds ... Innovation Quarter. Construction will begin immediately with plans to ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... world,s population is at risk of infection by the dengue virus, ... therapy to protect people from the virus could finally be a ... paper published today in the Proceedings of the National Academy ... Cancer Research, present a novel approach to developing a dengue therapy ...
... New York, NY and San Diego Calif. Proteins that ... aberrant signaling drives the wild proliferation of cells that gives ... receptor (EGFR), fuels a wide variety of cancersincluding a highly ... block its signaling tend to work only for a short ...
... by the human papilloma virus (HPV) has tripled since the ... This study discovered a new mechanism by which HPV causes ... that blocks the mechanism;, The findings could lead to ... COLUMBUS, Ohio Researchers have discovered a new mechanism ...
Cached Biology News:Research advances therapy to protect against dengue virus 2Research advances therapy to protect against dengue virus 3A hijacking of healthy cellular circuits 2A hijacking of healthy cellular circuits 3Researchers design drug to restore cell suicide in HPV-related head and neck cancer 2
... The IDS 25-Hydroxy Vitamin D ... the quantitative determination of 25-hydroxyvitamin D ... in human serum or plasma. Our ... inconvenience of solvent precipitation and centrifugation ...
... agarose suitable for a wide range of ... to Pulsed Field Gel Electrophoresis (PFGE). Due ... limits, Multi ABgarose can effectively separate large ... in turn means reduced band diffusion, a ...
Mouse monoclonal [1.F.1] to Yersinia pestis F1 antigen ( Abpromise for all tested applications). Antigen: Purified F1 antigen of Y. pestis vaccine strain EB....
Rabbit polyclonal to L Kynurenine ( Abpromise for all tested applications). Antigen: Synthetic peptide L Kynurenine conjugated to a protein carrier. Entrez Gene ID: 8942 Swiss Protein ID...
Biology Products: